McKesson (MCK) Stock Forecast & Price Target

$495.09

+11.42 (+2.36%)

(As of 10/8/2024 ET)

McKesson - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 16 Analyst Ratings

Sell
0

Hold
4

Buy
12

Based on 16 Wall Street analysts who have issued ratings for McKesson in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 4 have given a hold rating, and 12 have given a buy rating for MCK.

Consensus Price Target

$610.86
23.38% Upside

According to the 16 analysts' twelve-month price targets for McKesson, the average price target is $610.86. The highest price target for MCK is $670.00, while the lowest price target for MCK is $531.00. The average price target represents a forecasted upside of 23.38% from the current price of $495.09.

Get the Latest News and Ratings for MCK and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for McKesson and its competitors.

MCK Analyst Ratings Over Time

Type	Current Forecast 10/9/23 to 10/8/24	1 Month Ago 9/9/23 to 9/8/24	3 Months Ago 7/11/23 to 7/10/24	1 Year Ago 10/9/22 to 10/9/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	13 Buy rating(s)	14 Buy rating(s)	7 Buy rating(s)
Hold	4 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$610.86	$624.93	$596.00	$454.83
Forecasted Upside	23.38% Upside	23.95% Upside	1.56% Upside	0.68% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

[SHOCKING] Crypto Document Leak… (Ad)

Imagine if you could go back to 2009 and buy Bitcoin at $0.01. Or jump to 2015 and grab Ethereum at $0.75. We've created the next best thing: It's called "Crypto Revolution," and it's not just a book… it's your potential ticket to financial time travel.

Download your digital copy of "Crypto Revolution" now (limited-time offer).

MCK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MCK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

McKesson Stock vs. The Competition

Type	McKesson	Medical Companies	S&P 500
Consensus Rating Score	2.75	2.78	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	25.15% Upside	10,819.51% Upside	7.88% Upside
News Sentiment Rating	Neutral News See Recent MCK News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/7/2024	Leerink Partners 1 of 5 stars		Lower Target	Outperform ➝ Outperform	$665.00 ➝ $630.00	+29.78%
9/25/2024	Deutsche Bank Aktiengesellschaft 2 of 5 stars		Lower Target	Buy ➝ Buy	$623.00 ➝ $579.00	+20.99%
9/24/2024	Baird R W 0 of 5 stars	E. Coldwell Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
9/24/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Neutral	$603.00 ➝ $531.00	+5.15%
9/13/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$576.00 ➝ $535.00	+3.20%
9/10/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$670.00 ➝ $630.00	+24.10%
Get the Latest News and Ratings for MCK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for McKesson and its competitors with MarketBeat's FREE daily newsletter.
8/21/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$656.00 ➝ $661.00	+19.54%
8/8/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$596.00 ➝ $616.00	+12.78%
8/8/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral	$540.00 ➝ $570.00	+4.58%
8/8/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$660.00 ➝ $630.00	+2.02%
6/25/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$590.00 ➝ $670.00	+10.23%
6/24/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$570.00 ➝ $670.00	+11.10%
5/8/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$563.00 ➝ $652.00	+19.74%
5/8/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$620.00 ➝ $630.00	+14.00%
4/15/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$522.00 ➝ $548.00	+4.21%
2/26/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
8/11/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$450.00 ➝ $485.00	+11.71%
5/9/2023	58.com Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Maintains
11/2/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$384.00 ➝ $416.00	+5.96%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:34 PM ET.

Should I Buy McKesson Stock? MCK Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, September 30, 2024. Please send any questions or comments about these McKesson pros and cons to contact@marketbeat.com.

McKesson
Bull Case

Here are some ways that investors could benefit from investing in McKesson Co.:

McKesson Co. reported earnings per share of $7.88 for the last quarter, surpassing analysts' estimates by $0.67. This indicates strong financial performance and potential for growth.
McKesson Co. has a market capitalization of $63.45 billion, reflecting its size and stability in the market.
The company's revenue was up 6.4% compared to the same quarter last year, showing positive revenue growth.
McKesson Co. has a 52-week low of $431.35 and a 52-week high of $637.51, providing a clear range for investors to assess potential returns.
Institutional investors, such as Skandinaviska Enskilda Banken AB publ, have been increasing their stakes in McKesson Co., indicating confidence in the company's future prospects.

McKesson
Bear Case

Investors should be bearish about investing in McKesson Co. for these reasons:

McKesson Co. had a net margin of 0.94% and a negative return on equity of 242.57%, signaling potential financial challenges and inefficiencies.
The company's stock price traded down to $507.89, slightly lower than previous levels, which may indicate short-term volatility or market concerns.
Insiders at McKesson Co., including CEO Brian S. Tyler, have been selling shares of the company, which could be perceived as a lack of confidence in future performance.
McKesson Co. has a beta of 0.44, suggesting lower volatility compared to the market average, which may limit potential returns for more risk-seeking investors.
Despite positive revenue growth, McKesson Co.'s revenue of $79.28 billion for the last quarter fell short of analysts' expectations of $82.53 billion, raising concerns about future revenue generation.

MCK Forecast - Frequently Asked Questions

: According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for McKesson is $610.86, with a high forecast of $670.00 and a low forecast of $531.00.
: 16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last twelve months. There are currently 4 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" MCK shares.
: According to analysts, McKesson's stock has a predicted upside of 23.38% based on their 12-month stock forecasts.
: Over the previous 90 days, McKesson's stock had 1 downgrade by analysts.
: McKesson has been rated by research analysts at Baird R W, Barclays, Citigroup, Deutsche Bank Aktiengesellschaft, Evercore ISI, JPMorgan Chase & Co., Leerink Partners, Mizuho, Robert W. Baird, and Wells Fargo & Company in the past 90 days.
: Analysts like McKesson less than other "medical" companies. The consensus rating score for McKesson is 2.75 while the average consensus rating score for "medical" companies is 2.78. Learn more on how MCK compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

[SHOCKING] Crypto Document Leak… (Ad)

The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.

Download your digital copy now

This page (NYSE:MCK) was last updated on 10/8/2024 by MarketBeat.com Staff

From Our Partners